Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases

Epilepsy Research

Volumn 99, Issue 1-2, 2012, Pages 183-186

  Saruwatari, Junji ^a   Deguchi, Mariko ^a   Yoshimori, Yuki ^a   Noai, Madoka ^a   Yoshida, Shiho ^a   Ogusu, Naoki ^a   Oniki, Kentaro ^a   Yoshida, Shuichi ^b   Yasui Furukori, Norio ^c   Kaneko, Sunao ^c   Ishitsu, Takateru ^d   Nakagawa, Kazuko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d Kumamoto Saishunsou National Hospital   (Japan)

Author keywords

Glutamyltransferase; Alanine aminotransferase; Liver dysfunction; Non alcoholic fatty liver disease; Superoxide dismutase 2; Valproic acid

Indexed keywords

ALANINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; GAMMA GLUTAMYLTRANSFERASE; MANGANESE SUPEROXIDE DISMUTASE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALINE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALANINE; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SUPEROXIDE DISMUTASE; TRANSAMINASES; VALINE; VALPROIC ACID; YOUNG ADULT;

EID: 84857911879     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.10.033     Document Type: Article

References (11)

1. Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. J. Hepatol. 2011, 54:773-794.
2. Chateauvieux S., Morceau F., Dicato M., Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J. Biomed. Biotechnol. 2010, 10.1155/2010/479364.
3. Lee Y.H., Lin Q., Boelsterli U.A., Chung M.C. The Sod2 mutant mouse as a model for oxidative stress: a functional proteomics perspective. Mass Spectrom. Rev. 2010, 29:179-196.
4. Luef G., Rauchenzauner M., Waldmann M., Sturm W., Sandhofer A., Seppi K., Trinka E., Unterberger I., Ebenbichler C.F., Joannidis M., Walser G., Bauer G., Hoppichler F., Lechleitner M. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Res. 2009, 86:42-47.
5. Luef G.J., Waldmann M., Sturm W., Naser A., Trinka E., Unterberger I., Bauer G., Lechleitner M. Valproate therapy and nonalcoholic fatty liver disease. Ann. Neurol. 2004, 55:729-732.
6. Namikawa C., Shu-Ping Z., Vyselaar J.R., Nozaki Y., Nemoto Y., Ono M., Akisawa N., Saibara T., Hiroi M., Enzan H., Onishi S. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 2004, 40:781-786.
7. Radetti G., Kleon W., Stuefer J., Pittschieler K. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr. 2006, 95:833-837.
8. Silva M.F., Aires C.C., Luis P.B., Ruiter J.P., Ijlst L., Duran M., Wanders R.J., Tavares de Almeida I. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit. Metab. Dis. 2008, 31:205-216.
9. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003, 13:145-157.
10. Verrotti A., Agostinelli S., Parisi P., Chiarelli F., Coppola G. Nonalcoholic fatty liver disease in adolescents receiving valproic acid. Epilepsy Behav. 2011, 20:382-385.
11. Wallach J. Interpretation of Diagnostic Tests 1996, Little Brown and Company, New York. Sixth ed.